Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular Disease
Stefan Kiechl(Innsbruck Medical University), Johann Willeit(Innsbruck Medical University), Werner Poewe(Innsbruck Medical University), Gregor K. Wenning(Innsbruck Medical University), Agnes Mayr(University of Verona), Kurt Redlich(Medical University of Vienna), Georg Schett(Karolinska University Hospital), Martin Oberhollenzer(Krankenhaus Bruneck), Josef S. Smolen(Krankenhaus Bruneck), Peter Santer(Innsbruck Medical University)
Cited by 507
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
The Parkinson Progression Marker Initiative (PPMI)
|Progress in Neurobiology|2011|1.9k
Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes
|Circulation Research|2010|1.5k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k